78 results
8-K
EX-99.1
ARVN
Arvinas Inc
7 May 24
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:02am
options of $1.8 million.
Research and Development Expenses: Research and development expenses were $84.3 million for the quarter ended March 31 … , 2024, as compared with $95.3 million for the quarter ended March 31, 2023. The decrease in research and development expenses of $11.0 million
8-K
EX-99.1
ARVN
Arvinas Inc
27 Feb 24
Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:02am
), purchases of lab equipment and leasehold improvements of $2.9 million and losses on the sale of securities of $0.9 million.
Research and Development … Expenses: Research and development expenses were $379.7 million and $95.2 million for the year and quarter ended December 31, 2023, as compared with $315.0
S-3ASR
m8ec3 4pqm5x
8 Dec 23
Automatic shelf registration
9:16am
8-K
EX-99.1
g5k3yt72
6 Dec 23
Regulation FD Disclosure
7:01am
S-3ASR
lvv7cd0m
7 Nov 23
Automatic shelf registration
5:24pm
8-K
EX-99.1
m45i 8tjf98
7 Nov 23
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:03am
8-K
EX-99.1
eu3o u4parcub25b1
8 Aug 23
Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:03am
8-K
EX-99.1
yx5rbgzuhuw z7r2oc
5 May 23
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:30am
8-K
EX-99.1
yu2i9c3r3xyntun
9 Nov 22
Arvinas Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:28am
8-K
EX-99.1
ourceiw9i47buq4s9dl
5 Aug 22
Arvinas Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:12pm